[PDF][PDF] Identification of type I and type II interferon‐induced effectors controlling hepatitis C virus replication
P Metz, E Dazert, A Ruggieri, J Mazur, L Kaderali… - …, 2012 - Wiley Online Library
Persistent infection with hepatitis C virus (HCV) can lead to chronic hepatitis, liver cirrhosis,
and hepatocellular carcinoma. All current therapies of hepatitis C include interferon‐alpha …
and hepatocellular carcinoma. All current therapies of hepatitis C include interferon‐alpha …
[引用][C] Identification of Type I and Type II Interferon-Induced Effectors Controlling Hepatitis C Virus Replication
P METZ, E DAZERT, M BINDER… - Hepatology …, 2012 - pascal-francis.inist.fr
Identification of Type I and Type II Interferon-Induced Effectors Controlling Hepatitis C Virus
Replication CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Replication CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
[引用][C] Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication
P Metz, E Dazert, A Ruggieri, J Mazur, L Kaderali… - Hepatology, 2012 - cir.nii.ac.jp
Identification of type I and type II interferon-induced effectors controlling hepatitis C virus
replication | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
replication | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[PDF][PDF] Identification of Type I and Type II Interferon-Induced Effectors Controlling Hepatitis C Virus Replication
P Metz, E Dazert, A Ruggieri, J Mazur, L Kaderali… - …, 2012 - academia.edu
Materials and Methods RNAi-Based ISG Screening Assay. LucUbiNeoET cells13 (3 Â 105)
were seeded into 6-cm diameter dishes and transfected with 10 nM predesigned small …
were seeded into 6-cm diameter dishes and transfected with 10 nM predesigned small …
Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
P Metz, E Dazert, A Ruggieri, J Mazur… - Hepatology …, 2012 - europepmc.org
Conclusion Our study identifies a number of novel ISGs contributing to the suppression of
HCV replication by type I and type II IFN. We demonstrate a substantial overlap of antiviral …
HCV replication by type I and type II IFN. We demonstrate a substantial overlap of antiviral …
Identification of type I and type II interferon‐induced effectors controlling hepatitis C virus replication
P Metz, E Dazert, A Ruggieri, J Mazur, L Kaderali… - Hepatology, 2012 - infona.pl
Persistent infection with hepatitis C virus (HCV) can lead to chronic hepatitis, liver cirrhosis,
and hepatocellular carcinoma. All current therapies of hepatitis C include interferon‐alpha …
and hepatocellular carcinoma. All current therapies of hepatitis C include interferon‐alpha …
Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication
P Metz, E Dazert, A Ruggieri, J Mazur, L Kaderali… - Hepatology, 2012 - journals.lww.com
Persistent infection with hepatitis C virus (HCV) can lead to chronic hepatitis, liver cirrhosis,
and hepatocellular carcinoma. All current therapies of hepatitis C include interferon-alpha …
and hepatocellular carcinoma. All current therapies of hepatitis C include interferon-alpha …
Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication
P Metz, E Dazert, A Ruggieri… - Journal of …, 2012 - researchprofiles.canberra.edu.au
Persistent infection with hepatitis C virus (HCV) can lead to chronic hepatitis, liver cirrhosis,
and hepatocellular carcinoma. All current therapies of hepatitis C include interferon‐alpha …
and hepatocellular carcinoma. All current therapies of hepatitis C include interferon‐alpha …
Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication
P Metz, E Dazert, A Ruggieri… - Hepatology …, 2012 - pubmed.ncbi.nlm.nih.gov
Persistent infection with hepatitis C virus (HCV) can lead to chronic hepatitis, liver cirrhosis,
and hepatocellular carcinoma. All current therapies of hepatitis C include interferon-alpha …
and hepatocellular carcinoma. All current therapies of hepatitis C include interferon-alpha …
Identification of type I and type II interferon‐induced effectors controlling hepatitis C virus replication
P Metz, E Dazert, A Ruggieri, J Mazur, L Kaderali… - Hepatology, 2012 - infona.pl
Persistent infection with hepatitis C virus (HCV) can lead to chronic hepatitis, liver cirrhosis,
and hepatocellular carcinoma. All current therapies of hepatitis C include interferon‐alpha …
and hepatocellular carcinoma. All current therapies of hepatitis C include interferon‐alpha …